在2型糖尿病患者中添加斯皮罗诺拉克的效和安全性,这些患者接受了氨酶系统抑制剂治疗
Wei-Ren Lin1, Tzu-Shan Huang1, Ho-Hsiang Chang2
1Division of Nephrology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Clinical and translational science
|March 17, 2026
概括
在2型糖尿病 (T2D) 患者中,添加斯皮罗诺拉克 (spironolactone) 添加到氨酸 - ангиотензин系统抑制剂 (RASis) 可能会增加风险和高血症,但可以减少蛋白尿症. 心力衰竭状态显著影响这些结果,突出了个性化治疗需求.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
背景情况:
- 氨酶系统抑制剂 (RASis) 是治疗病的2型糖尿病 (T2D) 的标准.
- 对于T2D患有脏疾病的患者,与RASis结合使用螺旋的作用尚未完全理解.
研究的目的:
- 评价成人T2D患者在RASis中添加螺旋乳的结局和安全性.
- 为了研究心力衰竭对这些治疗效果的影响.
主要方法:
- 在国家成功大学医院 (2014-2021) 的T2D患者的回顾性研究.
- 倾向性得分匹配被用来比较RASis单独治疗的患者与RASis加螺旋.
- 考克斯的比例危险模型分析了复合结局,蛋白尿,心血管事件和高血症.
主要成果:
- 在RAS中添加螺旋乳增加了复合事件的风险,持续的eGFR下降和高血症.
- 螺旋龙的联合治疗与较高的蛋白尿减少的可能性有关.
- 心力衰竭状态改变的结果:HF患者的ESRD/移植风险较低,非HF患者的风险更高.
结论:
- 在T2D患者中,加上RASis的螺旋,可能会增加脏不良事件和高胆固醇血症,但减少蛋白尿.
- 心力衰竭显著改变了螺旋和结局之间的关联,强调了个性化医疗方法.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
1.7K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
3.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.8K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K
Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Antihypertensive Drugs: Potassium-Sparing Diuretics
2.6K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K


